Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents

Targeted acoustic contrast agents are designed to enhance the sensitivity and specificity of ultrasonic diagnoses. The authors have previously developed a ligand targeted ultrasonic contrast system which is a liquid, lipid encapsulated perfluorocarbon emulsion. The emulsion particles are small (250 nm) and have inherently low echogenicity unless bound to a surface by a pretargeted ligand through avidin-biotin interactions. The authors have recently proposed a simple acoustic transmission line model that treats the emulsion particles as a thin layer over the targeted surface. The acoustic reflectivity of the contrast layer is related to the longitudinal velocity and density of the perfluorocarbon. Improvement of the contrast effect may be achieved by using perfluorocarbons with slower longitudinal velocities and/or lower densities. The authors report the longitudinal velocities as a function of frequency of 20 perfluorocarbons using a broadband phase spectroscopic approach for estimating phase velocities. Experimentally determined velocities ranged from 520/spl plusmn/2 m/sec (perfluorohexane) to 705/spl plusmn/5 m/sec (perfluorodecalin). No measurable dispersion was observed over the useful bandwidth of 2 to 22 MHz. Increasing carbon backbone chain length and fluorine substitution with halogens of greater atomic weight increased the measured speed of sound. The authors' experimental data were consistent (R=0.87) with a published empirical model that predicts velocity as a function of molecular structure. These data provide a rational basis for optimizing targeted perfluorocarbon-based contrast agents and offer further insight into the physical mechanisms responsible for the observed enhancement of the acoustic scattering.

[1]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[2]  J. K. Spelt,et al.  Ultrasonic couplants for acoustic microscopy of low speed materials , 1997, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[3]  K. Shung,et al.  A novel method for the measurement of acoustic speed. , 1990, The Journal of the Acoustical Society of America.

[4]  S. Wickline,et al.  Quantitative intravascular ultrasound. Demonstration using a novel site targeted acoustic contrast agent , 1995, 1995 IEEE Ultrasonics Symposium. Proceedings. An International Symposium.

[5]  J. G. Miller,et al.  In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. , 1998, The Journal of the Acoustical Society of America.

[6]  M. André,et al.  Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. , 1984, The American journal of cardiology.

[7]  G. Leopold,et al.  Perfluorochemicals as liver‐ and spleen‐seeking ultrasound contrast agents. , 1983, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  J. Mobley,et al.  Broadband through-transmission signal loss measurements of Albunex® suspensions at concentrations approaching in vivo doses , 1997 .

[9]  J. G. Miller,et al.  Broadband measurements of phase velocity in Albunex suspensions. , 1998, The Journal of the Acoustical Society of America.

[10]  F. Forsberg,et al.  Contrast Agents in Ultrasound , 1995 .

[11]  T. Shawker,et al.  Lipid emulsions as contrast agents for hepatic sonography: an experimental study in rabbits. , 1985, Ultrasonic imaging.

[12]  N de Jong,et al.  Principles and recent developments in ultrasound contrast agents. , 1991, Ultrasonics.

[13]  Ye,et al.  Sound propagation in sodium di-2-ethyl-hexylsulfosuccinate micelles and microemulsions. , 1991, Physical review. A, Atomic, molecular, and optical physics.